Fig. 4: Expressions of S100A9, SPRR2A, and FABP5 among different SCCs.

A S100A9, SPRR2A, and FABP5 expressions in CESC, ESCA, HNSC, and LUSC. B Spearman’s rank correlation between each other in CESC. cervical squamous cell carcinoma and endocervical adenocarcinoma for CESC, esophageal carcinoma for ESCA, head and neck squamous cell carcinoma for HNSC, and lung squamous cell carcinoma for LSCC. *P < 0.05, **P < 0.01, and ***P < 0.001.